And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

Kirk Nielsen Biography and Net Worth

Director of Inari Medical

Kirk Nielsen has served as a member of our Board since September 2011. Mr. Nielsen has been a Managing Partner at Vensana Capital, a medtech-focused investment firm, since January 2019, and a Managing Director of Versant Ventures, a healthcare-focused venture capital firm since January 2011. He currently serves on the board of CVRx (NASDAQ: CVRX), a commercial-stage medical device company, where he serves as a member of the audit and nominating and corporate governance committees, and as a board member for several private companies. Mr. Nielsen received an A.B. from Harvard College and an M.B.A. from Harvard Business School.

What is Kirk G. Nielsen's net worth?: The estimated net worth of Kirk G. Nielsen is at least $62.55 million as of May 19th, 2022. Mr. Nielsen owns 1,685,466 shares of Inari Medical stock worth more than $62,547,643 as of April 23rd. This net worth evaluation does not reflect any other assets that Mr. Nielsen may own. Learn More about Kirk G. Nielsen's net worth.
How do I contact Kirk G. Nielsen?: The corporate mailing address for Mr. Nielsen and other Inari Medical executives is 9 Parker Suite 100, Irvine CA, 92618. Inari Medical can also be reached via phone at 877-923-4747 and via email at [email protected]. Learn More on Kirk G. Nielsen's contact information.
Has Kirk G. Nielsen been buying or selling shares of Inari Medical?: Kirk G. Nielsen has not been actively trading shares of Inari Medical during the last ninety days. Most recently, Kirk G. Nielsen sold 206 shares of the business's stock in a transaction on Friday, March 12th. The shares were sold at an average price of $120.00, for a transaction totalling $24,720.00. Following the completion of the sale, the director now directly owns 46,526 shares of the company's stock, valued at $5,583,120. Learn More on Kirk G. Nielsen's trading history.
Who are Inari Medical's active insiders?: Inari Medical's insider roster includes Mitch Hill (CFO), William Hoffman (CEO), Andrew Hykes (COO), Donald Milder (Director), Kirk Nielsen (Director), and Thomas Tu (Insider). Learn More on Inari Medical's active insiders.
Are insiders buying or selling shares of Inari Medical?: In the last year, Inari Medical insiders bought shares 1 times. They purchased a total of 54,000 shares worth more than $2,885,760.00. In the last year, insiders at the sold shares 25 times. They sold a total of 477,185 shares worth more than $29,387,024.73. The most recent insider tranaction occured on April, 16th when Director William Hoffman sold 1,451 shares worth more than $58,040.00. Insiders at Inari Medical own 10.6% of the company. Learn More about insider trades at Inari Medical.
Information on this page was last updated on 4/16/2024.

Kirk G. Nielsen Insider Trading History at Inari Medical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
3/12/2021	Sell	206	$120.00	$24,720.00	46,526

Kirk G. Nielsen Buying and Selling Activity at Inari Medical

Inari Medical Company Overview

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Today's Range

Now: $37.11

$36.81

$38.36

50 Day Range

MA: $46.48

$37.93

$59.03

2 Week Range

Now: $37.11

$36.73

$71.85

Volume

1,534,873 shs

Average Volume

1,132,125 shs

Market Capitalization

$2.15 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.84

He Is Giving Away Bitcoin

From Crypto Swap Profits | Ad

>> Register right here